Clinical Trial Update: Study of SHR-1209 Administered by Single-site or Multiple-site Subcutaneous Injections in Healthy Volunteers [Phase 1]

View source ↗

Summary

Phase 1 trial evaluating safety and pharmacokinetics of SHR-1209 administered by single-site or multi-site subcutaneous injections in healthy volunteers; the st…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypercholesterolemia
• Hyperlipidemia

Drugs mentioned

• SHR-1209

Snippet

Sponsor: Jiangsu HengRui Medicine Co., Ltd. | Conditions: Hypercholesterolemia and Hyperlipidemia | Phase 1 | Status: ACTIVE_NOT_RECRUITING